Testicular cancer survivors may have increased fatigue
the ONA take:
A recent study explored whether chronic fatigue is more prevalent in survivors of testicular cancer than the general population.
Researchers reviewed 812 testicular cancer survivors that were treated between 1980 and 1994. Respondents completed questionnaires and were also asked for blood samples.
Two surveys were conducted: Survey I (1998-2002) and Survey II (2007-2008). Logistic regression analysis was employed to examine associations between fatigue levels and Hospital Anxiety and Depression Scale (HADS), physical activity, hormone levels, treatment, neurotoxicity, and comorbidity.
The researchers, led by Dr. Jan Oldenburg (Department of Oncology, Akershus University Hospital, Lørenskog, Norway, & University of Oslo, Norway), found increased prevalence of chronic fatigue (15% up to 27% at Survey II). High neuropathy levels showed increased chronic fatigue (3-4-fold).
Higher levels of HADS-Anxiety and HADS-Depression showed increased chronic fatigue risk of 2-5-fold, respectively. Life style interventions, moderate physical activity, and treatment for depression/anxiety demonstrated some protective effect.
The study authors recommend additional research with extended, long-term follow-up reporting.
Recent study explored whether chronic fatigue is more prevalent in survivors of testicular cancer than the general population.
- Study Identifies Factors Associated With Hearing Loss in Polycythemia Vera
- High Symptom Burden With Polycythemia Vera Linked to QoL Impairment
- Bioimpedence Spectroscopy Improves Early Detection of Breast Cancer-Related Lymphedema in At-Risk Patients
- Ezh2 Inhibitors May Offer Cure for Chronic Myelogenous Leukemia
- MRD Negativity Associated With Prolonged Survival in Myeloma
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Sugar and Cancer: Mitigating the Affects of Diet on Cancer
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Tumor Markers (Fact Sheet)
- Implementing a Distress Screening Process for Cancer Patients
- ASCO, ASTRO Issue Guideline Update for Postmastectomy RT
- Study Assesses Efficacy of Ramucirumab in HCC by Child-Pugh Score
- Incontinence Affects QOL for Survivors of Gynecologic Cancers
- Patient Navigation Reduces Delays in Diagnostic Resolution
- Fee-for-service Medicare Plans Linked to Improved Care During Last Year of Life
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|